CorMedix (CRMD) Interest Expenses (2010 - 2026)
CorMedix (CRMD) posted Interest Expenses of -$947921.0 for Q4 2025, down 100.34% sequentially from $280.0 million in Q3 2025, and down 9972.12% YoY from N/an in Q4 2024.
CorMedix (CRMD) Interest Expenses (2010 - 2026) Analysis & Trends
CorMedix has reported Interest Expenses for 15 years, with the latest figure at -$947921.0 in Q4 2025.
- Quarterly Interest Expenses fell 9972.12% year-over-year to -$947921.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$880763.0 (down 851.77% YoY) and the FY2025 annual result came in at $113.3 million, up 380.86% from the prior year.
- Interest Expenses retreated to -$947921.0 in Q4 2025 per CRMD's latest filing, from $280.0 million in the prior quarter.
- Over five years, Interest Expenses peaked at $280.0 million in Q3 2025 and troughed at -$947921.0 in Q4 2025.
- A 5-year average of $14.9 million and a median of $110000.0 in 2024 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 548919.61% in 2025, down 9972.12% in 2025.
- Over 5 years, Interest Expenses stood at $5378.0 in 2021, then soared by 3270.4% to $181260.0 in 2022, then sank by 96.38% to $6556.0 in 2023, then soared by 46.46% to $9602.0 in 2024, then slumped by 9972.12% to -$947921.0 in 2025.
- According to Business Quant data, Interest Expenses over the past three periods registered -$947921.0, $280.0 million, and $2.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.80 Mn |
| Jun 30, 2026 | 1.80 Mn |
| Dec 31, 2025 | -947,921.00 |
| Dec 31, 2025 | -947,921.00 |
| Sep 30, 2025 | 280.00 Mn |
| Sep 30, 2025 | 280.00 Mn |
| Jun 30, 2025 | 2.39 Mn |
| Jun 30, 2025 | 2.39 Mn |
| Mar 31, 2025 | 530,000.00 |
| Mar 31, 2025 | 530,000.00 |
| Dec 31, 2024 | 9,602.00 |
| Dec 31, 2024 | 9,602.00 |
| Sep 30, 2024 | 51,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 169,000.00 |
| Jun 30, 2024 | 169,000.00 |
| Mar 31, 2024 | 169,000.00 |
| Mar 31, 2024 | 169,000.00 |
| Dec 31, 2023 | 6,556.00 |
| Dec 31, 2023 | 6,556.00 |